LFG
DYN icon

Larson Financial Group’s Dyne Therapeutics DYN Stock Holding History

Larson Financial Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4K Buy
796
+774
+3,518% +$13.3K ﹤0.01% 2027
2025
Q4 		$430 Buy
22
+3
+16% +$57 ﹤0.01% 3152
2025
Q3 		$240 Buy
+19
New +$217 ﹤0.01% 3235
2025
Q2 		– Sell
-46
Closed -$481 – 3341
2025
Q1 		$481 Buy
+46
New +$658 ﹤0.01% 2588

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Larson Financial Group's DYN Position: Q1 2026 in Review

Larson Financial Group increased its Dyne Therapeutics (DYN) stake by 3,518% in Q1 2026, buying an estimated $13.3K and bringing the position to 796 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Larson Financial Group first reported a position in DYN in Q1 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Larson Financial Group held 796 shares of Dyne Therapeutics worth $14.4K as of Q1 2026.
  • Larson Financial Group bought 774 Dyne Therapeutics shares in Q1 2026, an estimated $13.3K.
  • Dyne Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2027 holding.
  • Larson Financial Group first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.